- Home
- MLNK vs RCKT Comparison
MLNK vs RCKT Comparison
Compare MLNK & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLNK
- RCKT
- Stock Information
- Founded
- MLNK 1998
- RCKT 1999
- Country
- MLNK United States
- RCKT United States
- Employees
- MLNK N/A
- RCKT N/A
- Industry
- MLNK Computer Software: Prepackaged Software
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- MLNK Technology
- RCKT Health Care
- Exchange
- MLNK Nasdaq
- RCKT Nasdaq
- Market Cap
- MLNK 1.5B
- RCKT 1.3B
- IPO Year
- MLNK 2021
- RCKT N/A
- Fundamental
- Price
- MLNK $19.64
- RCKT $10.31
- Analyst Decision
- MLNK Hold
- RCKT Strong Buy
- Analyst Count
- MLNK 6
- RCKT 11
- Target Price
- MLNK $23.50
- RCKT $50.27
- AVG Volume (30 Days)
- MLNK 278.1K
- RCKT 1.8M
- Earning Date
- MLNK 03-04-2025
- RCKT 02-24-2025
- Dividend Yield
- MLNK N/A
- RCKT N/A
- EPS Growth
- MLNK N/A
- RCKT N/A
- EPS
- MLNK N/A
- RCKT N/A
- Revenue
- MLNK $311,440,000.00
- RCKT N/A
- Revenue This Year
- MLNK $5.98
- RCKT N/A
- Revenue Next Year
- MLNK $7.31
- RCKT $240,645.72
- P/E Ratio
- MLNK N/A
- RCKT N/A
- Revenue Growth
- MLNK 3.96
- RCKT N/A
- 52 Week Low
- MLNK $16.49
- RCKT $10.12
- 52 Week High
- MLNK $25.33
- RCKT $31.47
- Technical
- Relative Strength Index (RSI)
- MLNK 37.15
- RCKT 32.27
- Support Level
- MLNK $18.47
- RCKT $10.12
- Resistance Level
- MLNK $20.96
- RCKT $11.24
- Average True Range (ATR)
- MLNK 0.46
- RCKT 0.71
- MACD
- MLNK -0.03
- RCKT -0.09
- Stochastic Oscillator
- MLNK 39.97
- RCKT 5.88
About MLNK MeridianLink Inc.
MeridianLink Inc is a cloud-based software solution for financial institutions, including banks, credit unions, mortgage lenders, specialty lending providers, and consumer reporting agencies. It generates maximum revenue from Lending Software Solutions.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.